I. Centers for Disease Control and Prevention . Recommendations of the Immunization Practices Advisory Committee (ACIP): General recommendations on immunization. MMWR. 1994;43(RR-1) .
2 . Lum LG, Munn NA, Schanfield MS, Storb R. The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood 1986;67:582-7.
3. Lum LG, Seigneuret MC, Storb R. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients. J Clin Immunol
1986;6:389-96
4. Wimperis JZ, Brenner MK, Prentice HG, et al. Transfer of a functioning humoral immune system in transNantation of T-lymphocyte-depleted bone marrow Lancet 1986;1:339-43
5. Baumgartner C, Morell A, Hirt A, et al. Humoral immune function in pediatric patients treated with autologous bone marrow transplantation for Bcellnon-Hodgkin's lymphoma. The influence of ex vivo marrow decontamination with anti-Y 29/55 monoclonal antibody and complement. Blood 1988;71:1211-17.
6. Ljungman P, Fridell E, Lonnqvist B, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989;159:610-5.
7. Ljungman P, Wiklund Hammarsten M, Duraj V, et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect
Dis 1990;162:496-500.
8. Rege K, Mehta J, Treleaven J, et al. Fatal pneumococcal infections following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:903-6.
9. Aucouturier P, Barra A, Intrator L, et al. Long lasting IgG subclass and antibacterial polysaccbaride antibody deficiency after allogeneic bone marrow transplantation. Blood 1987;70:779-85.
10. Lossos IS, Breuer R, Or R, at al. Bacterial pneumonia in recipients of bone marrow transplantation. Afive-year prospective study. Transplantation
1995;60:672-8.
II. Ljungman P, Cordonnier C, De Bock R, et al. Immunizations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995;15:455-60.
12. Somani 3, Larson RA. Re-immunization after allogeneic bone marrow transplantation. Am J Med 1995;98:389-98.
13. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987;69:369-80.
14. Symann M, Bosly A, Gisselbrecht C, Brice P, Franks C. Immune reconstitution after bone-marrow transplantation. Cancer Treat Rev 1989;16 (Suppl A):15-9.
15. Atkinson K. Reconstruction of the hemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5:209-26.
16. Kelsey SM, Lowdell MW, Newland AC. IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation. Clin Exp Immunol 1990;80:409-12.
17. Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992;9:395-408.
18. Storek 3, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. Bcell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993;12:387-98.
19. Storek S; Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995;16:413-25.
20. Roberts MM, To LB, Gillis D, et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993;12:469-75.
21. Ottinger HD, Beelen DW; Scheulen B, Schaefer UW; Grosse-Wilde H. Improved immune reconstitution after allo-transplantation of peripheral blood stem cells instead of bone marrow. Blood 1996;88:2775-9.
22. Singhal S, Powles R, Treleaven 3, Long S, Rowland A, Mehta J. Comparison of cell yields in a double-blind randomized study of allogeneic marrow vs. b1ood stem cell transplantation. Br J Haematol 1996;93 (Suppl
1):37.
23. Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol 1995;11:95-105.
24. Gratama JW, Verdonck LF, van der Linden JA, et al. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation. Transplantation 1986;41:719-24.
25. Li Volti S, Mauro L, Di Gregorio F, et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant
1994;14:225-7.
Turgut Özal Tıp Merkezi Dergisi 5(2,3):1998
203
Vaccination strategies in patients with bone marrow transplantation
26. Barra A, Cordonnier C, Preziosi MP, et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J
Infect Dis 1992;166:1021-8.
27. Guinan EC, Molrine DC, Antin JH, et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation
1994;57:677-84.
28. Molrine DC, Guinan EC, Antin JH, et al. Donor immunization with Haemophilus influenzae type b (Hib)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996;87:3012-8.
29. Ilan Y, Nagler A, Adler R, et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.
Hepatology 1993;18:246-52.
30. Nagler A, Ilan Y, Adler R, et al. Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Bone Marrow Transplant 1995;15:475-8.
31. Ilan Y, Nagler A, Adler R, Tur Kaspa R, Slavin S, Shouval D. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology 1993;104:1818-21.
32. Ilan Y, Nagler A, Shouval D, et al. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors. Clin Exp Immunol 1994;97:299-302
33. Potter MN, Foot AB, Oakhill A. Influenza A and the virus associated hemophagocytic syndrome: cluster of three cases in children with acute leukemia. J Clin Pathol 1991;44:297-9.
34. Whimbey E, Eiting LS, Couch RB, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow
Transplant 1994;13:437-40.
35. Engelhard D, Nagler A, Hardan I, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993;11:1-5.
36. Pauksen K, Duraj V; Ljungman P, et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992;9:427-32.
37. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V, et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994;84:657-63.
38. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the
Americas. Evolving strategies. JAMA 1996;275:1311-12.
39. Witherspoon RP, Storb R, Ochs HD, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and anti-thymocyte globulin treatment. Blood 1981;58:360-8.
40. Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA, Gale RP. Pneumococcal vaccination of recipients of bone marrow transplants. Arch
Intern Med 1983;143:1735-7.
41. Lortan JE, Vellodi A, Jurges ES, Hugh-Jones K. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 1992;88:512-9.
42. Avanzini MA, Carra AM, Maccario R, et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 1995;15:137-44.
43. Hammarstrom V, Pauksen K, Azinge J, Oberg U, Ljungman P. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence ofgraft-versus-host reaction. Support Care Cancer 1993;1:195-9.
44. de Quadros CA, Andrus JK, Olive JM, Carrasco P. Strategies for poliomyelitis eradication in developing countries. Public Health Rev 1993-
94;21:65-81.
45. Anonymous. Progress towards global poliomyelitis eradication, 1985¬1994. MMWR 1995;44:273-5,281.
46. Engelhard D, Handsher R, Naparstek E, et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow
Transplant 1991;8:295-300.
47. Ljungman P, Duraj M Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant
1991;7:89-93.
48. Pauksen K, Hammarstrom V, Ljungman P, et al. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 1994;18:547-52.
49. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045-52.
50. Wimperis JZ, Brenner MK, Prentice HG, Thompson EJ, Hoffbrand AV. B cell development and regulation after T cell-depleted marrow transplantation. J Immunol 1987;138:2445-50.
51. Gerritsen EJ, van Tol MJ, van't Veer MB, et al. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
Blood 1994;84:4374-82.
52. Shepherd DM, Noelle RJ. The lackofmemoryB cells in immune bone marrow. Transplantation 1991;52:97-100.
53. Wimperis JZ, Gottlieb D, Duncombe AS, Heslop HE, Prentice HG, Brenner MK. Requirements for the adoptive transfer of antibody responses to a priming antigen in man. J Immunol 1990;144:541-7.
54. Gottlieb DJ, Cryz SJ Jr, Furer B, et al. Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients.
Blood 1990;76:2470-5.
55. Riddell SR. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Sem Resp Infect 1995;10:199-208.
56. Heslop HE, Ng JY, Li C, Smith CA, Loftin SK, Krance RA, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T-lymphocytes. Nature Med
1996;2:551-5.
57. Barnes RA. Immunotherapy and immunoprophylaxis in bone marrow transplantation. J Hosp Infect 1995;30(Suppl):223-31.
58. Khouri IF, Ippoliti C, Gajewski J, Przepiorka D, Champlin RE. Neutropenias following allogeneic bone marrow transplantation: response to therapy with increased dose intravenous immunoglobulin.
Am J Hematol 1996;52:313-5.
59. Dal-Re R, Gil A, Gonzalez A, Lasheras L. Does tetanus immune globulin interfere with the immune response to simultaneous administration of tetanus-diphtheria vaccine? A comparative clinical trial in adults. J Clin
Pharmacol 1995;35:420-5.
Thank you for copying data from http://www.arastirmax.com
